Table 1.
Sensitivity and specificity of the cfDNA paired ctDNA methylation test and CEA in patients with tumor load and normal controls
| Biopsy finding | ctDNA methylation test (n = 612)* | CEA test (n = 612) * | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Positive results (n) | Negative results (n) | Sensitivity % | Specificity % | n | Positive results (n) | Negative results (n) | Sensitivity % | Specificity % | |
| Stage I | 3 | 3 | 0 | 100.0 | 3 | 0 | 3 | 0.0 | ||
| Stage II | 32 | 21 | 11 | 65.6 | 32 | 9 | 23 | 28.1 | ||
| Stage III | 85 | 66 | 19 | 77.6 | 85 | 35 | 50 | 41.2 | ||
| Stage IV | 185 | 161 | 24 | 87.0 | 185 | 123 | 62 | 66.5 | ||
| Total | 305 | 251 | 54 | 82.3 | 305 | 167 | 138 | 54.8 | ||
| Normal controls | 307 | 14 | 293 | 95.4 | 307 | 9 | 298 | 97.1 | ||
*Patients with tumor load were included in the sensitivity analysis